Alerje Funding & Investors
Alerje develops an emergency medicine and digital oral immunotherapy management platform to improve the quality of life for those affected by food allergies. Its online platform and app enable users to create food allergy profiles, share the profiles, filter recipes based on the profiles, and also scan grocery items to detect allergens in the ingredients. It also features an epinephrine auto-injector that integrates into a smartphone case for improved patient adherence and alerts, and its National Science Foundation (NSF) validated food allergy oral immunotherapy (OIT) adherence platform collects, stores, analyzes, and distributes alerts and notifications.
alerje.comTotal Amount Raised: $3,060,331
Alerje Funding Rounds
Grant
$1,000,000
Grant Investors
National Science FoundationGrant
$255,331
Grant Investors
National Science FoundationGrant
$50,000
Grant Investors
GoogleSeed
$1,000,000
Seed Investors
AngelStartup HealthJustin AndersonJumpstart NovaQuantum Medical ConceptsInvest DetroitUnseen CapitalTech Startup Stabilization FundMichigan RisePre Seed
$30,000
Pre Seed Investors
WillowWorksGrant
$250,000
Grant Investors
CTIPGrant
$25,000
Grant Investors
Accelerate Michigan Innovation CompetitionPre Seed
$410,000
Pre Seed Investors
AngelBrian LuerssenBackstage CapitalSherwin PriorInvest DetroitWillowWorksGrant
$40,000
Grant Investors
Google for Startups